These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38309307)

  • 1. Miltefosine reduces coxsackievirus B3 lethality of mice with enhanced STAT3 activation.
    Zhang CY; Hung CH; Hsiao YL; Chang TM; Su YC; Wang LC; Wang SM; Chen SH
    Antiviral Res; 2024 Mar; 223():105824. PubMed ID: 38309307
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Fu Q; Gao L; Fu X; Meng Q; Lu Z
    J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
    [No Abstract]   [Full Text] [Related]  

  • 3. STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression.
    Liang T; Zhang Z; Bai Z; Xu L; Xu W
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
    Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
    J Virol; 2021 May; 95(12):. PubMed ID: 33827951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
    Liu H; Li M; Song Y; Xu W
    Front Immunol; 2018; 9():2479. PubMed ID: 30410495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.
    Sharma A; Marceau C; Hamaguchi R; Burridge PW; Rajarajan K; Churko JM; Wu H; Sallam KI; Matsa E; Sturzu AC; Che Y; Ebert A; Diecke S; Liang P; Red-Horse K; Carette JE; Wu SM; Wu JC
    Circ Res; 2014 Aug; 115(6):556-66. PubMed ID: 25015077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.
    Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL
    mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways.
    Wang X; Li M; Yu Y; Liu G; Yu Y; Zou Y; Ge J; Chen R
    J Cell Physiol; 2019 Aug; 234(10):18029-18040. PubMed ID: 30843214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71.
    Zhu G; Wu C; Wang Q; Deng D; Lin B; Hu X; Qiu F; Li Z; Huang C; Yang Q; Zhang D
    Antiviral Res; 2023 Mar; 211():105553. PubMed ID: 36737007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
    Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Mechanisms of Saucerneol from
    Song JH; Mun SH; Yang H; Kwon YS; Kim SR; Song MY; Ham Y; Choi HJ; Baek WJ; Cho S; Ko HJ
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38275951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral and myocyte protective effects of IL-28A in coxsackievirus B3-induced myocarditis.
    Wang S; Huang X; Zhang J; Huang C
    Braz J Infect Dis; 2015; 19(2):132-40. PubMed ID: 25528576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of interferon-gamma-inducible GTPase inhibits coxsackievirus B3-induced apoptosis through the activation of the phosphatidylinositol 3-kinase/Akt pathway and inhibition of viral replication.
    Zhang HM; Yuan J; Cheung P; Luo H; Yanagawa B; Chau D; Stephan-Tozy N; Wong BW; Zhang J; Wilson JE; McManus BM; Yang D
    J Biol Chem; 2003 Aug; 278(35):33011-9. PubMed ID: 12819192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
    Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
    Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.
    Su R; Shereen MA; Zeng X; Liang Y; Li W; Ruan Z; Li Y; Liu W; Liu Y; Wu K; Luo Z; Wu J
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effects of interferon-β are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3.
    Burke JD; Sonenberg N; Platanias LC; Fish EN
    Antivir Ther; 2011; 16(4):577-84. PubMed ID: 21685545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3.
    Wang Y; Zhuan X; Peng Y; Li Q; Huang C; Huang H; Liang Z; Wang Q; Chang J
    Acta Virol; 2021; 65(1):58-67. PubMed ID: 33827222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.